BIOMAT Database Logo BIOMAT Database Logo

[Fucidin, its basic properties and place in the modern therapy of suppurative and inflammatory processes]. 1976

S M Navashin, and I P Fomina, and M A Petrova, and S M Kuznetsova, and V P Pozdniakova

Sodium fusidin prepared at the All-Union Research Institute of Antibiotics was studied experimentally and clinically. High antibacterial activity of fusidin especially against methicillin-resistant staphylococci was found. The clinical trials showed high efficacy of fusidin in treatment of perichondritis, osteomyelitis, pyodermia, pseudofurunculosis, multiple abscesses of the skin because of its satisfactory penetration into the skin and cartilage tissues, skin and subcutaneous cellular tissue. The tolerance of the drug by most of the patients was satisfactory.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005672 Fusidic Acid An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis. Fucithalmic,Fusidate Sodium,Fusidic Acid, Sodium Salt,Fusidin,Silver Fusidate,Sodium Fusidate,Stanicide,Acid, Fusidic,Fusidate, Silver,Fusidate, Sodium,Sodium, Fusidate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S M Navashin, and I P Fomina, and M A Petrova, and S M Kuznetsova, and V P Pozdniakova
[The use of vacuum therapy in suppurative inflammatory processes].
May 1967, Klinicheskaia khirurgiia,
S M Navashin, and I P Fomina, and M A Petrova, and S M Kuznetsova, and V P Pozdniakova
Digitalis: its place in modern therapy.
November 1980, Drugs,
S M Navashin, and I P Fomina, and M A Petrova, and S M Kuznetsova, and V P Pozdniakova
[Sleep therapy in certain acute, suppurative inflammatory processes].
January 1951, Vestnik khirurgii imeni I. I. Grekova,
S M Navashin, and I P Fomina, and M A Petrova, and S M Kuznetsova, and V P Pozdniakova
[Modern trends in the treatment of chronic suppurative bronchopulmonary processes].
April 1957, Minerva medica,
S M Navashin, and I P Fomina, and M A Petrova, and S M Kuznetsova, and V P Pozdniakova
[Use of trimecaine in suppurative inflammatory processes].
November 1973, Voenno-meditsinskii zhurnal,
S M Navashin, and I P Fomina, and M A Petrova, and S M Kuznetsova, and V P Pozdniakova
[Local antibiotic therapy in the treatment of cutaneous, subcutaneous and intramuscular inflammatory and suppurative processes].
January 1956, Prensa medica argentina,
S M Navashin, and I P Fomina, and M A Petrova, and S M Kuznetsova, and V P Pozdniakova
[Penicillin therapy of suppurative processes].
July 1952, Medicinski glasnik,
S M Navashin, and I P Fomina, and M A Petrova, and S M Kuznetsova, and V P Pozdniakova
[Acute inflammatory suppurative processes of the pterygomandibular space].
June 1954, Osterreichische Zeitschrift fur Stomatologie,
S M Navashin, and I P Fomina, and M A Petrova, and S M Kuznetsova, and V P Pozdniakova
[X-ray therapy and various immunologic indices in the complex treatment of suppurative-inflammatory processes].
February 1984, Vestnik khirurgii imeni I. I. Grekova,
S M Navashin, and I P Fomina, and M A Petrova, and S M Kuznetsova, and V P Pozdniakova
[Drainage for treatment of suppurative-inflammatory processes].
January 1975, Vestnik khirurgii imeni I. I. Grekova,
Copied contents to your clipboard!